NCT03951870View on ClinicalTrials.gov

Characterization of the Relationship Between the Human Mesolimbic Reward System and Immune Functioning

NACompletedINTERVENTIONAL
Enrollment

85

Participants

Timeline

Start Date

January 20, 2019

Primary Completion Date

August 28, 2022

Study Completion Date

August 28, 2022

Conditions
Immune Hepatitis
Interventions
BEHAVIORAL

Neuromodulation via fMRI Neurofeedback task

Two active neurofeedback groups will practice to up regulate their designated neural targets via identical experimental protocol (varying only the origin of the feedback).

BIOLOGICAL

Hepatitis B vaccination

Subjects will be vaccinated against Hepatitis B

Trial Locations (1)

Unknown

Functional Brain Center, Sourasky Medical Center, Tel Aviv

All Listed Sponsors
collaborator

Technion, Israel Institute of Technology

OTHER

lead

Tel-Aviv Sourasky Medical Center

OTHER_GOV

NCT03951870 - Characterization of the Relationship Between the Human Mesolimbic Reward System and Immune Functioning | Biotech Hunter | Biotech Hunter